Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy

Eur Urol. 2017 Dec;72(6):1025-1026. doi: 10.1016/j.eururo.2017.09.020. Epub 2017 Sep 28.

Authors

David D'Andrea¹, Shahrokh F Shariat²

Affiliations

¹ Department of Urology, Medical University of Vienna, Vienna, Austria.
² Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USA. Electronic address: sfshariat@gmail.com.

PMID: 28964632
DOI: 10.1016/j.eururo.2017.09.020

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Transitional Cell
Chemotherapy, Adjuvant
Cisplatin
Cystectomy*
Humans
Neoadjuvant Therapy*
Retrospective Studies
Treatment Outcome
Urinary Bladder Neoplasms

Substances

Cisplatin